Two seconds – and the nasal mucosa gets a protective barrier from viruses

Clinically proven

Agovirax Nasal Spray
N

Indicated for prophylaxis and treatment of respiratory infections caused by viruses in adults and children from 1 year of age.

Effective barrier against more than 200 viruses. Clinically proven

Common cold and flu-like illnesses are caused by a large variety of viruses, such as rhinoviruses, coronaviruses, and others. If viruses have penetrated into the nose, they can attach themselves to the mucous membrane and infect mucosal cells where they multiply and spread.

Agovirax® Nasal Spray creates a protective barrier on the nasal and oral mucosa thus preventing binding and entry of the respiratory viruses into the cells. Thereby viruses cannot attach to the mucosal cells and infection is stopped.

Clinically proven

Agovirax may strongly reduce the risk of the SARS-CoV-2 infection and virus spread

Iota-carrageenan (active substance of Agovirax) inhibits the cell entry of SARS-CoV-2. The latest in vitro study confirmed, that “iota-carrageenan inhibits the cell entry of SARS-CoV-2 (…), which suggests that administration of iota-carrageenan may be effective and safe prophylaxis or treatment also for SARS-CoV-2 infections“. [1]

Iota-carrageenan forms a protective barrier & prevents viruses from entering your body

Iota carrageenan creates a protective barrier on the nasal and oral mucosa thus preventing binding and entry of the respiratory viruses, including coronaviruses, into the cells.

Clinically proven

Clinically proven

So safe, that it can be used during pregnancy, breastfeeding and by children over 1 year. Also, multiple times a day.

  •  AGOVIRAX has localised effects. Carragelose® Iota-carrageenan is not absorbed by the cells of the mucosa. It has no other side effects besides very rare cases of hypersensitivity.
  • AGOVIRAX can be used for a longer period of time. There is no potential for addiction or risk of overdose.
  • AGOVIRAX contains no analgesics, no preservatives, no constituents of animal origin nor greenhouse gases. It is lactose and gluten-free and can be used by diabetics and vegans.

Results of clinical studies

  • Agovirax reduces the viral load (number of viruses) in mucus membranes by more than 90%. [1]
  • Agovirax shortens the duration of the disease on average by 2.1 days. [2]
  • Agovirax significantly lowers frequency of relapses. [2]
  • Agovirax reduces the common cold symptoms. [1]

Clinically proven

Active virus protection barrier for up to 3 hours in two seconds

Use each time before being exposed to potential viruses.